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Abstract
Background: Recombinant expression and purification of metallo-enzymes, including hydrogenases, at high-yields is
challenging due to complex, and enzyme specific, post-translational maturation processes. Low fidelities of maturation
result in preparations containing a significant fraction of inactive, apo-protein that are not suitable for biophysical or
crystallographic studies.
Principal Findings: We describe the construction, overexpression and high-yield purification of a fusion protein consisting
of the algal [2Fe2S]-ferredoxin PetF (Fd) and [FeFe]-hydrogenase HydA1. The maturation of Fd-HydA1 was optimized
through improvements in culture conditions and media components used for expression. We also demonstrated that fusion
of Fd to the N-terminus of HydA1, in comparison to the C-terminus, led to increased expression levels that were 4-fold
higher. Together, these improvements led to enhanced HydA1 activity and improved yield after purification. The strong
binding-affinity of Fd for DEAE allowed for two-step purification by ion exchange and StrepTactin affinity chromatography.
In addition, the incorporation of a TEV protease site in the Fd-HydA1 linker allowed for the proteolytic removal of Fd after
DEAE step, and purification of HydA1 alone by StrepTactin. In combination, this process resulted in HydA1 purification yields
of 5 mg L21 of culture from E. coli with specific activities of 1000 U (U= 1 mmol hydrogen evolved mg21 min21).
Significance: The [FeFe]-hydrogenases are highly efficient enzymes and their catalytic sites provide model structures for
synthetic efforts to develop robust hydrogen activation catalysts. In order to characterize their structure-function properties
in greater detail, and to use hydrogenases for biotechnological applications, reliable methods for rapid, high-yield
expression and purification are required.
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Introduction
The direct conversion of low potential electrons into hydrogen
by microbial organisms is a prospective biotechnological process
for the renewable hydrogen production as an energy carrier
[1,2,3]. Photosynthetic microbes, for example green algae [4,5,6]
and cyanobacteria [7], can couple light-driven water oxidation to
generate hydrogen, whereas anaerobes produce hydrogen utilizing
the reduced electron carriers generated by fermentation [8,9]. In
both examples, the hydrogen producing reactions are catalyzed by
hydrogenases. Hydrogenases catalyze hydrogen activation by
virtue of unique organometallic clusters that compose the catalytic
sites [10,11]. Based on the metal compositions of the catalytic sites,
the hydrogenases organize into phylogenetic groups representing
three enzyme subclasses [11,12]. These are; (i) [NiFe]-hydroge-
nases found in cyanobacteria, archaea and eubacteria; (ii) iron-
sulfur-cluster-free hydrogenases, for example HMD hydrogenase
from the methanogen Methanothermobacter marburgensis [13,14]; and
(iii) [FeFe]-hydrogenases found in anaerobic eubacteria and
protozoans, and green algae. The [FeFe]-hydrogenases, which
are the focus of this investigation, generally exhibit a catalytic bias
towards hydrogen production, possess high kcat values, monomeric
compositions and show high sensitivity to oxygen [3]. Because of
these properties, [FeFe]-hydrogenases, as well as [NiFe]-hydrog-
enases, are being investigated to understand the structural basis for
both fast hydrogen activation rates [15] and for oxygen tolerance
[14,16] towards achieving efficient natural and artificial solar
hydrogen production systems [17,18,19].
In recent years, several groups have developed different
strategies for the recombinant expression of [FeFe]-hydrogenases
[20] (see Table 1). These include using either native [FeFe]-
hydrogenase expressing organisms as hosts [21,22], or Escherichia
coli for heterologous expression. Initial expression efforts in E. coli
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relied on co-expression of the required maturation genes HydE
and HydFG from Chlamydomonas reinhardtii [23]. Due to the
instability of the C. reinhardtii genes in E. coli, an expression system
was developed utilizing the HydE, HydF and HydG maturation
genes along with the HydA structural gene from Clostridium
acetobutylicum [24]. A similar approach was also used for co-
expression of the Shewanella oneidensis maturation genes in E. coli
where improvements in growth conditions resulted in higher
expression levels and recovery yields of 30 mg L21 of culture [25].
However, the maturation efficiencies based on the Fe content and
specific activities indicated H-cluster incorporation was not
complete. In addition, the purification of recombinant hydroge-
nases is most often performed by use of affinity tags, for example
His or StrepII-tag, at the N- or C-terminus [21,22,24,25,26]. In
most cases affinity purification is performed as a single-step process
that typically results in rather low yields, and purities at or greater
than 80%. Although suitable for biochemical characterization,
both crystallization and biophysical studies require production of
large quantities of samples that are also high in purity and quality.
Recently, we have reported on the design and expression of a
fusion protein composed of the [2Fe2S] Fd PetF and the [FeFe]-
hydrogenase HydA1 from C. reinhardtii [26]. Here, we show that
the addition of the Fd as a fusion partner to HydA1 facilitated
higher expression and purification yields of HydA1 [FeFe]-
hydrogenase. These effects were observed when Fd was fused to
the N-terminus rather than the C-terminus of HydA1. Moreover,
by incorporating a TEV protease site in the fusion linker it was
possible to remove the Fd prior to the final affinity step, resulting
in pure HydA1. After this final step, HydA1 preparations
possessed .95% Fe incorporation and specific activities of
1000 U (U = 1 mmol hydrogen mg21 min21) for hydrogen
evolution from reduced methyl viologen (MV). In summary, the
Fd fusion based expression process improved both the yields and
maturation fidelities of recombinant [FeFe]-hydrogenase HydA1
production in E. coli.
Results
Construction of Fd-HydA1 fusion protein with a cleavable
TEV linker
For this work, an Fd-HydA1 fusion was created that
incorporated two unique protease sites, one for proteolytic
cleavage of Fd from HydA1 and one for removal of the HydA1
C-terminal StrepII-tag. The peptide linker that connects Fd to
HydA1 incorporated the TEV protease site ENLYFQ(G/S)
[27,28], and the HydA1 C-terminus includes a Factor Xa cleavage
followed by the StrepII-tag (Figure 1A). This construct was sub-
cloned into the T7 expression plasmid pHydE [24], which harbors
the maturation protein C. acetobutylicum HydE gene, to create
pHydEFd-HydA1 (Figure 1B). Both pHydEFd-HydA1 and
plasmid pHydFHydG [11] were co-transformed into E. coli
BL21 (DE3) Rosetta-2, which in the presence of IPTG co-
expresses the three maturation proteins, HydE, HydF and HydG,
together with Fd-HydA1.
Optimization of culture conditions for recombinant
[FeFe]-hydrogenase expression
This recombinant expression of [FeFe]-hydrogenases in E. coli is
a multi-step process involving use of temperature shifts, differential
gas-phase conditions, and culture vessels [11]. An extensive screen
of each of these parameters, together with media and antibiotic
formulations was performed to improve [FeFe]-hydrogenase
expression yields and activities using Fd-HydA1 for testing.
Terrific broth (TB) was used as the base media formulation due
its use for high-level expression of Fd [29]. This was confirmed by
comparing HydA1 expression yields in TB to those from cells
grown in LB or minimal media. Cultures grown in TB consistently
produced significantly higher HydA1 yields, thus TB was selected
for optimization of additional growth factors and conditions. For
HydA1 and Fd-HydA1 expression, cultures are grown in four
steps; the first three were performed under aerobic conditions and
the last under anaerobic conditions, described as follows:
i) Day 1. An overnight 10 ml aerobic starter culture (ON).
ii) Day 2. Small aerobic starter culture. A 1:100 dilution of the
ON into 10 ml of fresh media (SD1).
iii) Day 2. Large aerobic large culture. A 1:100 dilution of SD1
into 1 L of fresh media (SD2).
iv) Days 2 and 3. Anaerobic expression culture. The SD2 is
transferred to a gas-tight, anaerobic bottle, equilibrated
under argon for 1 h and incubated overnight under an H2/
N2 atmosphere. (AC)
The first culture parameter that was tested for optimization was
the aeration rate during growth of SD2. While common
expression protocols suggest 200–250 rpm shaking, we found that
a more rapid rotation rate of 300–350 rpm resulted in 2-fold
higher Fd-HydA1 expression levels, based on whole-cell activity
assays (Figure 2A). Since HydA1 and Fd are both iron-sulfur
proteins, we also tested the effect of different iron supplementation
levels used during AC on whole-cell activities. A concentration
range of ferric ammonium citrate (FEC) was added at the start of
the AC phase at the same time as the addition of IPTG. Based on
the activity levels, the optimal value of FEC was 2–3 mM final
(Figure 2B). The effect of IPTG concentration was also tested and
found to be optimal at levels of only 0.4 mM (Figure 2C). Two
types of antibiotics are required to stably maintain the expression
plasmids; Streptomycin (Str) (pHydFHydG) and ampicillin (Amp)
for the pHydEFd-HydA1 (Figure 1B). While Str is stable under
culture conditions, Amp is gradually degraded by accumulation of
Table 1. HydA1 purification yields and specific activities from
various expression hosts.
Host
Specific
activitya Total yieldb Iron contentc Ref
C. reinhardtii 730 0.04 NR [33]
C. reinhardtii 935 0.001 3.960.3 [34]
S. oneidensis 740 0.5 6.160.1 [22]
C.
acetobutylicum
625 1 NR [30]
C.
acetobutylicum
760 0.1 NR [21]
E. coli 150 1 NR [24]
E. coli 641 30 4.560.2 [25]
E. coli 400 1.5 NR [26]
E. coli 1000 5 5.6460.28 Current work
aHydA1 specific activities for hydrogen evolution by MV assay; 1 U= mmol
hydrogen min21 mg21.
bHydA1 mg L21 of cell culture.
cIron content as mol iron (mol HydA1)21; NR, not reported.
doi:10.1371/journal.pone.0035886.t001
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extracellular b-lactamases during growth. When Amp was
replaced with Carbenicillin (Carb), which is less easily degraded
by b-lactamases, expression levels increased up to 2-fold at
200 mg ml21 (Figure 2D). Interestingly, we found that the
presence of antibiotic is crucial only for the ON and SD1 steps,
whereas if the SD2 and AC steps could be performed in the
absence of antibiotics, with no loss in Fd-HydA1 yields (data not
shown). When the culture modifications were combined into a
single process, the hydrogenase yields and whole-cell activity levels
increased ,10-fold, from 0.5 mg L21 of culture at 2 mmol
hydrogen ml21 min21 to 5 mg L21 of culture at 20 mmol
hydrogen ml21 min21. In comparison to our previous studies
[13], the improvement led to 3-fold increase in purification yield
from 1.5 to 5 mg L21 of culture, and a 6-fold increase in whole-
cell activities from 3.5-to 22 mmol hydrogen ml21 min21.
Two-step purification of Fd-HydA1
Once expression and maturation were optimized, a new
purification protocol was developed to optimize both yields and
activities of Fd-HydA1. This involved a two-step process of ion
exchange chromatography by DEAE followed by affinity chro-
matography with StrepTactin. After cell disruption and clarifica-
tion, the soluble fraction was loaded directly onto a series of four
pre-packed 5 ml DEAE columns. The high, overall negative
charge of Fd enabled the tight binding of Fd-HydA1 to DEAE,
and the Fd-HydA1 enriched fraction was eluted in a single step
with 500 mM NaCl. Due to the additional presence of Fd, the
sodium dithionite (NaDT)-reduced Fd-HydA1 fusion was a clear
brown color, which enabled monitoring of protein elution visually
without the need for a UV-Vis spectrometer (Figure 3A). The
presence of Fd-HydA1 in each step of purification, from lysate
preparation to column loading and elution, is evident by the dark
brown color (see Figure 3A). Once Fd-HydA1 was purified
(Figure 3B), the Fd moiety was removed by proteolytic cleavage
using MBP-TEV as described in the Methods Section. Separation
of HydA1 from the TEV digestion mixture was performed by
StrepTactin affinity chromatography (Figure 3C). For this step it
was critical to use high concentrations (1 M) of NaCl in the
StrepTactin buffers, the use of lower NaCl concentrations resulted
in the loss of HydA1 during loading. Even with the addition of
1 M NaCl, there was considerable migration of the bound HydA1
on the resin during the washing step, which resulted in a loss in the
HydA1 yields. To overcome this, four 5 ml StrepTactin columns
were combined in series to increase the bed volume. Elution of the
pure HydA1 was performed using desthiobiotin and was evident as
a green-brown enriched HydA1 fraction (Figure 3C).
Figure 1. Diagrams of the Fd-HydA1 fusion protein and the pHydEFd-HydA1 expression plasmid developed for the study. (A). A
schematic of the N-terminal Ferredoxin-HydA1 fusion protein showing the relative positions of Ferredoxin, (Fd) peptide linker with TEV protease site
(TEV protease), HydA1 and the Factor XA Protease and StrepII-tag (Strep II). HydA1 (C. reinhardtii HYDA1) is the mature protein sequence (without the
chloroplast transit peptide). (B). The pHydEFd-HydA1 plasmid is a derivative of pETDuet (Invitrogen, USA) that allows for IPTG-inducible co-expression
of the HydE and Fd-HydA1 proteins [11]. The relative locations of HydE, Fd, TEV protease site, HydA1, Factor Xa protease site and the StrepII tag are
shown. T7P1, T7 polymerase promoter 1; T7P2, T7 polymerase promoter 2; T7ter, T7 transcriptional terminator; AmpR, ampicillin resistance marker;
pBR322 ori, origin of replication; and LacI, lactose repressor gene.
doi:10.1371/journal.pone.0035886.g001
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The N-terminal location of Fd enhances expression of the
Fd-HydA1 fusion
To determine how Fd contributed to the enhancement of
hydrogenase activity levels in whole-cells expressing Fd-HydA1,
we first compared the expression levels of N-terminal and C-
terminal Fd fusions. As shown in Figure 4A, after equal loading of
total cell protein, the N-terminal Fd fusion showed higher
expression levels than those of the C-terminal Fd fusion. This
was also evident from comparing clarified cell lysates containing
N-terminal (Figure 4A, inset image right) or C-terminal (Figure 4A,
inset image left) fusion. This difference was confirmed by
separation of equivalent amounts of soluble fractions by SDS-
PAGE and Western Blot with antibodies against the StrepII-tag
(Figure 4A lower inset). The levels of the N-terminal fusion (right)
are several times higher than the C-terminal fusion (left).
Interestingly, the whole-cell MV activities are consistent with the
expression results where the average cell-free extract activities for
the N-terminal Fd fusion were 22 mmol hydrogen ml21 min21
compared to 7 mmol hydrogen ml21 min21 for C-terminal Fd-
HydA1 at an equivalent OD600 value. In summary, the results
indicate that the total HydA1 expression levels are elevated by
300–400% due to the presence of the N-terminal versus C-
terminal location of Fd.
Optimization of TEV digestion of Fd-HydA1
To determine the accessibility of the TEV recognition site in Fd-
HydA1 for digestion, Fd-HydA1 was first purified by DEAE and
StrepTactin chromatography. Different amounts of commercial
TEV (TurboTEV, Eton Bioscience) were added to a fixed amount
(30 mg) of Fd-HydA1 and the digestion was performed for 1 h at
37uC. We found that 4 mg of TEV or a w/w ratio of 1:7.5
TEV:Fd-HydA1 was sufficient for complete digestion (Figure 4B).
The same TEV:Fd-HydA1 ratio was also shown to result in
complete digestion of fusion-enriched fractions from the DEAE
purification step (Figure 4C). We repeated the digestion procedure
using purified TEV-MBP and obtained similar results, thus TEV-
MBP was used for the purification and analysis of HydA1
described below.
Analysis of purified HydA1
We were able to obtain high purity HydA1 at concentrations of
,2.5 mg ml21 directly from StrepTactin columns by performing
the TEV-MBP proteolytic digestion step after the DEAE
chromatography. The purity was evaluated by SDS-PAGE and
coomassie blue-staining (Figure 4D). The measured specific
activity of the HydA1 in the MV activity assay was 1000 U,
which compares well to previously published results [30]. It should
Figure 2. Influence of growth factors on the in vitro hydrogen evolution activities in cells harboring pHydEFd-HydA1 and
pHydFHydG. Hydrogenase activities (reported in units of nmol hydrogen evolved, ml21 of culture, min21) in solubilized whole-cells were measured
as described in materials and methods. (A). The effect of the shaker rotation speed (RPM) during the aerobic growth phase was tested for 100 ml or
1 L culture volumes grown in. 250 ml or 2 L baffled flasks, respectively. The optimal rate was for both culture volumes was ,300–350 RPM. (B). The
effect of ferric ammonium citrate (FEC) concentration. Optimal levels were 2–2.5 mM. (C). Effect of IPTG concentration. Optimal levels of IPTG were
0.4 mM, lower than the 1.5 mM used previously [13]. (D). Effect of substituting Ampicillin with Carbenicillin during all stages of growth. Addition of
Carbenicillin at 200 mg ml21 was required for peak hydrogenase activity levels.
doi:10.1371/journal.pone.0035886.g002
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be noted that after a freeze and thaw (e.g. when stored
anaerobically at 280uC) the specific activity (MV) of pure HydA1
decreased from 1000 U to 300 U. Currently, we have no
explanation for this observed loss of HydA1 MV activity following
enzyme storage (see discussion below). However, this specific
activity level of frozen stocks remained stable at 300–400 U over a
period of several months at 280uC. The iron contents of purified
HydA1 were determined as previously described [31], and found
to be on average 5.64 (+/20.28) mol iron (mol HydA1)21, which
indicates 94% incorporation based on 6 atoms of iron per HydA1.
Overnight digestion of HydA1 with Factor Xa resulted in
complete removal of the StrepII-tag.
Discussion
The heterologous expression of metallo-enzymes, specifically
hydrogenases, requires optimization of both protein expression
and maturation processes, and each process can significantly affect
the final production levels and enzyme qualities. In this study, we
described an optimized protocol for recombinant production of
[FeFe]-hydrogenase in E. coli developed from expression of an Fd-
HydA1 fusion. We found that the major factors that contributed to
increased expression levels were conditions that maintained more
aerobic growth (i.e., baffled flasks and rotation rates .350 rpm),
and the utilization of Carbenicillin in place of Ampicillin at the
start of anaerobic expression phase. Together these two factors
resulted in a 3-fold elevation in HydA1 yields compared to our
previous report [13], or an increase from 1.5 to 5 mg L21 of
culture. It should be noted that it is possible that the expression
protocol can be optimized even further from optimization of other
growth factors and conditions that were not specifically tested
here.
In our previous study [26] the specific activity value of the N-
terminal Fd-HydA1 fusion was 2800, whereas HydA1 alone was
,7-fold lower, or 400 U. By applying the purification protocol
developed here, we showed an increase from 2800 to 3500 U in
the MV activity assay for Fd-HydA1 (25% increase), which
declined 3.5-fold to 1000 U after proteolytic removal of the Fd.
We speculate that the effect of Fd (the decline in activity by
cleavage, or in the opposite case the increase due to the presence
of Fd in the fusion) is due to a kinetic advantage from the lower KM
of Fd (,300-fold lower than for reduced MV [30]) for HydA1,
which effectively increases the rate of MV reduction of HydA1 in
Fd-HydA1 versus HydA1 alone. Nonetheless, the HydA1 activity
value of 1000 U was still 60% higher than our previously reported
value of 400 U. Thus, both the presence of Fd, and revised
purification protocol, resulted in isolation of HydA1 with higher
specific activity. We hypothesize that fusion of Fd to the HydA1 N-
terminus enhanced either the maturation (possibly through
reductive activation following H-cluster insertion) or the stability
(by maintaining HydA1 in a reduced state in the presence of
NaDT) to result in HydA1 with improved specific activities.
Finally, we showed that the presence of Fd also improved enzyme
recovery during purification by lowering the overall pI to result in
higher affinity on DEAE during the ion-exchange step.
The quality of the purified HydA1 was determined in two ways.
First, the specific activity was 1000 U based on the MV dependent
hydrogen evolution assay. Second the iron incorporation per
HydA1 as mol iron (mol HydA1)21 was found to be 5.64+/20.28,
or 94%. Unfortunately, the specific activity level of 1000 U was
not maintained during prolonged storage at 280uC in an
anaerobic gas-pak jar, after several months the activity values
typically declined to a range of 300–400 U. The same HydA1
samples were studied by FTIR spectroscopy and also showed
evidence of an exogenous CO absorption peak indicative of the
CO-inhibited H-cluster (data not shown) [32]. Thus, under these
storage conditions, the loss in activity correlates with the formation
of the CO-inhibited form of HydA1. Formation of the CO
inhibited HydA1 in frozen samples has been observed by other
groups (see [32,33]), and would arise from H-cluster decomposi-
tion and release of CO, which in turn binds to a second enzyme.
The net result would be a loss in specific activity of the enzyme
pool (from 1000 U to 400 U) due to enzyme degradation.
In conclusion, we have developed an improved recombinant
expression and the purification process in E. coli for algal [FeFe]-
hydrogenase, and for the [FeFe]-hydrogenases in general.
Moreover, the basis for the optimization in both the expression
and purification steps is not specific for [FeFe]-hydrogenases, and
might be useful for improving the recombinant expression and
purification of other metallo-enzymes.
Methods
Plasmid construction
Plasmid constructs for the expression of C. reinhardtii [FeFe]-
hydrogenases (HydA1) in E. coli were developed from the
pETDuet based plasmids pHydEHydA1 and pHydFHydG as
described [24]. Modifications to pHydEHydA1 exchanged the C.
reinhardtii HydA1 structural gene without any other alterations of
HydE. To create the N-terminal Fd-HydA1 fusion, the nucleotide
sequence encoding the mature form of [FeFe]-hydrogenase
HydA1 (Ala57-Lys497) was fused to C-terminus of the mature
form of the C. reinhardtii PetF (Ala32-Tyr126) (referred to here as
Fd) with a 15 amino acid (aa) linker containing a TEV protease
Figure 3. Illustrated purification steps. As shown in the schematic,
clarified, cell-free lysates were separated on DEAE ion-exchange and the
pooled hydrogenase active fractions were separated on StrepTactin
columns. (A). During elution from StrepTactin, a distinct brown band
was evident that contained the StrepII tagged HydA1. (B). Purified Fd-
HydA1, showing the intense red-brown coloration due to the addition
of Fd, after single-step elution from StrepTactin in buffer containing
12.5 mM desthiobiotin and 500 mM NaCl. (C). TEV proteolytic removal
of Fd after the DEAE step resulted in a color change from red-brown to
green-brown of the purified HydA1.
doi:10.1371/journal.pone.0035886.g003
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recognition site (Thr-Gly-Gly-Gly-Ser-Glu-Asn-Leu-Tyr-Phe-Gln-
Gly-Gly-Ala-Ser). This gene constructs was optimized for E. coli
expression and synthesized by GeneArt. The synthetic Fd-HydA1
gene was sub-cloned into NdeI, AvrII digested pHydEHydA1
replacing the existing HYDA1 gene with the Fd-HydA1 fusion This
construct also contained a C-terminal extension (59-ctcgagatt-
gaaggccgtcaattgggctggagccatccgcagtttgaaaaataacctagg-39) encod-
ing the Factor Xa and StrepII-tag (Figure 1).
MBP-TEV protease expression and purification
To express and purify TEV protease, an expression plasmid
containing a gene for the TEV protease fused to Maltose binding
protein (MBP) was used. The original TEV-MBP fusion was
developed by Kapust et al. [28], and later cloned under control of
the arabinose promoter by the Benhar group at Tel Aviv
University (Prof. I. Benhar personal communication). Expressions
were performed in E. coli BL21 (DE3) Rosetta-2 (Novagen). A
10 ml volume of Luria-Bertani (LB) media containing
200 mg ml21 Carbenicillin was cultured overnight at 37uC.
100 ml of culture was diluted into 10 ml of LB with the same
concentration of antibiotics and cultured at 37uC with shaking at
250 rpm until the OD600 reached 0.4. 5 ml of the pre-culture was
added to 0.5 L of fresh LB media and cultured until the OD600
reached a value of 0.8. Cells were induced by addition of 0.2%
arabinose and cultured for an additional 4 h at 30uC and
150 rpm.
Cells were collected by centrifugation at 70006g for 7 min at
4uC, and re-suspended in a 15 ml volume of buffer A (Table 2)
without dithionite or glycerol. Cells were disrupted in a French
Press for 1 min at 1200 psi. The cell debris was removed by
centrifugation at 45,000 rpm in a 60Ti rotor (Beckman) for
30 min at 4uC. Clarified lysates (usually 30–40 ml) were loaded on
15 ml amylose resin columns (NEB) pre-equilibrated with buffer
A. The column was washed with 50 ml of buffer A, and elution
was carried out in buffer A containing 10 mM maltose. About
30 mg of MBP-TEV was obtained from 0.5 L of culture.
Fd-HydA1 expression
All expressions were performed in E. coli BL21 (DE3) Rosetta-2
(Novagen). A 10 ml volume of LB containing 200 mg ml21
Carbenicillin and 50 mg ml21 Streptomycin was cultured over-
night at 37uC. 100 ml of cells were diluted into 10 ml of Terrific-
Broth (TB) with the same concentration of antibiotics and cultured
at 37uC with shaking at 250 rpm until absorbance value at OD600
reached 0.4. 10 ml of the pre-culture was added into 1 L of fresh
TB media in baffled plastic flasks (VWR) and cultured to an
Figure 4. SDS-PAGE analysis of Fd-HydA1 expression, TEV digestion and HydA1 purification. (A). A comparison of the expression levels
of N-terminal and C-terminal Fd-HydA1 fusions by separation on SDS-PAGE. Lanes show (left to right) protein size marker, SM, with sizes in kDa, and
increasing amounts (0.5-to-4 ml) of total protein from cells expressing either the C-terminal (Fd C) or N-terminal (Fd N) Fd-HydA1 fusions. The location
of ,60 kDa Fd-HydA1 fusion, and 53 kDa HydG as an internal loading control are marked. The difference of Fd position on Fd-HydA1 expression
levels was evident as a more intense brown color of the cell-lysates (inset image, top) harboring the N-terminal (right) versus C-terminal (left) Fd
fusion. A Western Blot performed with antibodies to the StrepII-tag is shown (inset image, bottom) where the N-terminal fusion (right) exhibits a
more intense band than the C-terminal fusion (left). (B). Analysis of TEV digestions of the N-terminal Fd-HydA1 fusion (30 mg) mixed with 1, 2, 4, or
8 mg of TEV (lanes 1–4, respectively). Lanes 2 and 3 show a partial digestion. The locations of Fd-HydA1 (60 kDa), HydA1 (50 kDa) and Fd (10 kDa) are
indicated on the right. The optimal amount of TEV for complete digestion was 4 mg (shown in lane 3). Protein size-marker, SM, with sizes in kDa. (C).
TEV digestions of DEAE pooled fractions containing Fd-HydA1 and separated on SDS-PAGE. The same w/w ratio of TEV to Fd-HydA1 was used as for
purified Fd-HydA1 (4 mg TEV with 30 mg of DEAE pool). Lane 1, complete TEV digest; Lane 2, partial TEV digest; Lane 3, no TEV. Bands corresponding
to Fd-HydA1 (60 kDa), HydA1 (50 kDa) and Fd (10 kDa) are identified on the right. HydG is identified as a loading control. (D). Analysis of HydA1
purity by SDS-PAGE. Protein size marker, SM, with sizes in kDa. Lanes 1–4 contain 1.4, 4, 6.8, and 12.3 mg, respectively, of purified HydA1 at .99%
purity.
doi:10.1371/journal.pone.0035886.g004
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OD600 value of 0.4. For induction, the culture was transferred to
1 L bottles (Kimax-25) fitted with a V-shape rubber cap and the
following supplements were added: fresh ammonium ferric citrate
(2.5 mM final), IPTG (1.5 mM final), sodium fumarate (25 mM
final), glucose (0.5% final), and cysteine (2 mM final). The bottles
were sparged with argon for 1 h at 22uC, after which cultures were
transferred to an anaerobic glove box (Coy Laboratories) under
4% H2 (balance N2) atmosphere and incubated over night at
20uC.
Fd-HydA1 purification
Due to the oxygen sensitivity of HydA1, all buffers contained
20 mM NaDT. Cells were collected by centrifugation at 70006g
for 7 min at 4uC, and were re-suspended in a 15 ml volume of
buffer A (Table 2). Cells were disrupted by Ultrasonication at
5630 s intervals, and the lysate centrifuged at 45,000 rpm in a
60Ti rotor (Beckman) for 30 min at 4uC. Clarified lysates (usually
30–40 ml) were loaded onto a series of 365 ml DEAE FF columns
(GE Healthcare) pre-equilibrated in buffer B at a flow rate of
5 ml min21. The column was washed at 5 ml min21 first with
50 ml of buffer B, followed by 50 ml of buffer C. Elution was
carried out in buffer D at a flow rate of 2.5 ml min21. The pooled
brown fractions (usually 7–10 ml) were combined and digested by
addition of 4 ml of MBP-TEV protease (1 mg ml21) for 1 h at
37uC. The NaCl concentration was adjusted to 1 M, and the
digested enzyme pool was loaded at 1 ml min21 onto a series of
465 ml StrepTactin columns (GE Healthcare) pre-equilibrated
and washed in 50 ml of buffer E. HydA1 was eluted in buffer F
and 1 ml fractions collected. Protein concentrations were
quantified by Bradford assay (Bio-Rad) according to manufacturer
instructions. Purified enzymes were stored at 280uC in an
anaerobic gas-pak jar (Mitsubishi).
Protein gel electrophoresis
Protein gel electrophoresis was performed with NuPAGEH
NovexH Bis-Tris Gel Systems (Invitrogen) according to manufac-
turer instructions.
Western blot
Samples were prepared by dilution of 30 ml of cell lysate into
10 ml LDS sample buffer and 4 ml reducing agent (Invitrogen), and
incubated at 95uC for 5 min. A 10 ml volume of the reduced
sample were resolved on Novex 10% Bis-Tris SDS-PAGE gels
(Invitrogen), and transferred to a 0.45 mm nitrocellulose mem-
brane in an iBlot (Invitrogen). Blots were blocked overnight in PBS
containing 3% BSA and 0.5% Tween-20, and washed three times
with PBST. Washed blots were incubated 1 h with Mouse Anti
Strep-tagH Antibody-Horse Radish Peroxidase conjugate (Pierce)
diluted in 1:10 in PBS containing 0.2% BSA, 0.5% Tween-20, and
further diluted 1:2500 in PBST. Strep-tagged proteins were
visualized using the ECL-Plus Kit (GE Healthcare) and western
blot images were captured using a Fluor Chem gel documentation
system (Alpha Innotech).
Hydrogen production assays of solubilized E. coli whole-
cells and purified hydrogenase
Reaction buffer stock solutions were prepared in the anaerobic
glove box in a 30 ml sealed serum vial. Methyl viologen (Sigma)
was added with NaDT (20 mM final) to 25 ml of buffer G
(Table 2) to working concentrations of 20 mM, or 40 mM
respectively. The MV reaction buffer was sparged under argon
for 20 min. Each sample (10 ml) was diluted into 1 ml of buffer G
and added to a stoppered 13 ml serum vial. Sample solutions were
sparged with argon for an additional 5 min, and 1 ml of the
reaction buffer (MV or Fd) was injected to the sample using a gas-
tight syringe. Reactions were mixed and then incubated at 37uC
for 10–20 min. The headspace hydrogen was measured by gas
chromatograph (GC, Hewlett-Packard 5890 Series II) fitted with a
5 A˚ mol sieve column (Supelco). 1 unit (U) of hydrogen evolution
activity is equivalent to 1 umol hydrogen evolved min21 mg21 for
purified samples, and 1 umol hydrogen evolved min21 (ml of
culture)21 for cell-free extracts.
Iron content measurement
Spectrophotometric determination of iron content in purified
HydA1 samples was performed as described by Fish [31].
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Table 2. Buffers used for protein purification.
Buffer Application step Composition
A Cells lysis Tris-HCl 100 mM, pH 8; glycerol 5% v/v; NaDT 20 mM; protease inhibitor
(Sigma) 250 ml L21 of culture; lysozyme 84 mg ml21; benzonase (Sigma)
5 ml L21 of culture
B 1st wash buffer for DEAE Tris-HCl 100 mM, pH 8; glycerol 5% v/v; NaDT 20 mM
C 2nd wash buffer for DEAE Tris-HCl 100 mM, pH 8; glycerol 5% v/v; NaDT 20 mM; NaCl 0.05 M
D DEAE elution buffer Tris-HCl 100 mM, pH 8; glycerol 5% v/v; NaDT 20 mM; NaCl 0.5 M
E StrepTactin wash buffer Tris-HCl 100 mM, pH 8; glycerol 5% v/v; NaDT 20 mM; NaCl 1 M
F StrepTactin elution buffer Tris-HCl 100 mM, pH 8; glycerol 5% v/v; NaDT 20 mM; desthiobiotin
12.5 mM
G Methyl viologen activity assays Tris-HCl 100 mM, pH 8; glycerol 5% v/v; KCl 0.25 M; triton X-100 0.2% v/v
for whole-cell assays.
doi:10.1371/journal.pone.0035886.t002
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